메뉴 건너뛰기




Volumn 51, Issue 2, 2013, Pages 247-248

Lessons from controversy: Biomarkers evaluation

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

EID: 84875471752     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0012     Document Type: Editorial
Times cited : (7)

References (10)
  • 1
    • 84872040796 scopus 로고    scopus 로고
    • Biomarker failures
    • Ioannidis JP. Biomarker failures. Clin Chem 2013;59:202-4.
    • (2013) Clin Chem , vol.59 , pp. 202-204
    • Ioannidis, J.P.1
  • 2
    • 84867009373 scopus 로고    scopus 로고
    • Commercial immunoassays in biomarker studies: Researchers beware
    • Rifai N, Watson ID, Miller WG. Commercial immunoassays in biomarker studies: researchers beware! Clin Chem 2012;58:1387-8.
    • (2012) Clin Chem , vol.58 , pp. 1387-1388
    • Rifai, N.1    Watson, I.D.2    Miller, W.G.3
  • 3
    • 79956088412 scopus 로고    scopus 로고
    • What information should be required to support clinical "omics" publications
    • Baggerly KA, Coombes KR. What information should be required to support clinical "omics" publications? Clin Chem 2011;57:688-90
    • (2011) Clin Chem , vol.57 , pp. 688-690
    • Baggerly, K.A.1    Coombes, K.R.2
  • 4
    • 81755160935 scopus 로고    scopus 로고
    • Regulation of in vitro diagnostics (IVD) for use in clinical diagnostic laboratories: Towards the light or dark in clinical laboratory testing
    • Favaloro EJ, Plebani M, Lippi G. Regulation of in vitro diagnostics (IVD) for use in clinical diagnostic laboratories: towards the light or dark in clinical laboratory testing. Clin Chem Lab Med 2011;49:1965-73.
    • (2011) Clin Chem Lab Med , vol.49 , pp. 1965-1973
    • Favaloro, E.J.1    Plebani, M.2    Lippi, G.3
  • 5
    • 77954241512 scopus 로고    scopus 로고
    • Evaluating laboratory diagnostics tests and translational research
    • Plebani M. Evaluating laboratory diagnostics tests and translational research. Clin Chem Lab Med 2010;48:983-8.
    • (2010) Clin Chem Lab Med , vol.48 , pp. 983-988
    • Plebani, M.1
  • 6
    • 67049086198 scopus 로고    scopus 로고
    • Challenges of the "omics" future and pathology informatics systems
    • Yee KC. Challenges of the "omics" future and pathology informatics systems. Arch Pathol Lab Med 2009;133: 938-41.
    • (2009) Arch Pathol Lab Med , vol.133 , pp. 938-941
    • Yee, K.C.1
  • 7
    • 51349127776 scopus 로고    scopus 로고
    • Evaluating new diagnostic technologies: Perspective in the UK and US
    • Price CP, Christenson RH. Evaluating new diagnostic technologies: perspective in the UK and US. Clin Chem 2008;54:1421-3.
    • (2008) Clin Chem , vol.54 , pp. 1421-1423
    • Price, C.P.1    Christenson, R.H.2
  • 8
    • 76149128044 scopus 로고    scopus 로고
    • Medicare and medical technologies - The growing demand for relevant outcomes
    • Neumann PJ, Tunis SR. Medicare and medical technologies - the growing demand for relevant outcomes. N Engl J Med 2010;362:377-9.
    • (2010) N Engl J Med , vol.362 , pp. 377-379
    • Neumann, P.J.1    Tunis, S.R.2
  • 9
    • 20444374342 scopus 로고    scopus 로고
    • ACCE: A model process for evaluating data on emerging genetic tests
    • In: Khouri M, Little J, Burke W, editors. Oxford: Oxford University Press
    • Haddow J, Palomaki G. ACCE: a model process for evaluating data on emerging genetic tests. In: Khouri M, Little J, Burke W, editors. Human genome epidemiology. Oxford: Oxford University Press, 2004: 217-33.
    • (2004) Human Genome Epidemiology , pp. 217-233
    • Haddow, J.1    Palomaki, G.2
  • 10
    • 40949157539 scopus 로고    scopus 로고
    • Evaluating diagnostic tests
    • Walley T. Evaluating diagnostic tests. Br Med J 2008;336: 569-70.
    • (2008) Br Med J , vol.336 , pp. 569-570
    • Walley, T.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.